Navigation Links
Autism Consortium releases data on genes involved in autism to researchers worldwide
Date:10/22/2007

BOSTON OCTOBER 22, 2007 The Autism Consortium, a group of researchers, clinicians and families dedicated to radically accelerating research and enhancing clinical care for autism, announced today that it has completed the first genome scan for Autism Spectrum Disorders (ASD) through its Autism Gene Discovery Project and has released the reference data set to a database that autism researchers around the world can use. The scan was conducted using new, high resolution technology developed by Affymetrix on genetic data from more than 3,000 children with ASD and their families.

Todays release of genetic and phenotypic data on autism marks a significant achievement for the autism research community, said Thomas Insel, Ph.D., Director of the National Institute for Mental Health. Progress in finding the causes and cures for autism spectrum disorders rests in large part on improving the rapid access and sharing of data and resources That the Consortium is making the data available to the scientific community even before its own researchers have fully analyzed the information, demonstrates their high degree of commitment to and leadership in advancing autism research.

Along with complementary data generated by Dr. Aravinda Chakravarti at Johns Hopkins and provided to the NIMH this week, these data provide the most detailed look to date at the genetic variation patterns in families with autism.

Mark Daly, PhD, a Consortium member with the Center for Human Genetic Research at Massachusetts General Hospital and a senior associate member of the Broad Institute of Massachusetts Institute of Technology and Harvard, released genetic data from genome wide scans of DNA variation collected from 3,000 individuals who are either affected by autism spectrum disorders, or are family members of individuals with autism. DNA samples for this scan were provided by the Autism Genetic Resource Exchange (AGRE), a program of Autism Speaks, dedicated to ac
'/>"/>

Contact: Kathryn Morris
kathryn@kmorrispr.com
845-635-9828
The Autism Consortium
Source:Eurekalert

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. Antibiotics Helps Autism
2. Early diagnosis for autism from blood tests may be possible
3. Latest discovery on Autism
4. Resolving Autism
5. Studying The Causes Of Autism
6. Mercury Pollution Linked To Rise In Autism
7. Early identification of autism possible
8. Autism risks linked to birth factors
9. Autism epidemic is a myth- says a new study
10. Treating Autism More Effectively
11. MMR Vaccination not linked to Autism

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...RNewswire/ -- Major League Baseball,s Mark Teahe...ls and recently acquired by the Chicago White Sox,...ard is given annually to a Major League Baseball p...dedication of baseball great Fred Hutchinson, both...dlands, Calif., native made his MLB debut with the...
(Date:11/30/2009)...esidents of ,stroke belt, study finds , ...orn in the "stroke belt" of the southern United St...e than others, even if they live elsewhere later, ...te people born in the North and South Carolina, Ge...a show a consistently higher incidence of stroke c...
(Date:11/30/2009)... notes a rise in child deaths linked to flu, , .... health officials said Monday that H1N1 swine flu...ven as the number of American children dying from ...ort, released Monday by the U.S. Centers for Disea...s to doctors for influenza-like illness nationally...
(Date:11/30/2009)...ov. 30 Jedi Mind, Inc ....sed to announce the Company,s first thought-contro...The game, "Think-Tac-Toe" is the first of its kind...power of their mind and is geared towards people o...e of $49 and can be purchased directly through the...
(Date:11/30/2009)...land, Nov. 30 Tyco Inter...its 2010 annual general meeting of shareholders wi...m. Central European time at the Park Hyatt Zurich ...and. Registered shareholders as of January 11, 201...e annual general meeting. Additionally, individua...
Breaking Medicine News(10 mins):Health News:Mark Teahen Named 2009 Hutch Award Winner 2Health News:Birth in South Raises Stroke Risk for Life 2Health News:Birth in South Raises Stroke Risk for Life 3Health News:U.S. Swine Flu Cases Chart Sharp Decline 2Health News:U.S. Swine Flu Cases Chart Sharp Decline 3Health News:First Thought-Controlled Game Complete From Jedi Mind, Inc. 2
...if., Jan. 12 ,Watson Pharmaceuticals, Inc. (NYSE: ...X ) announced today that they have entered into Se... patent litigation related to Warner Chilcott,s,or...,to Warner Chilcott,s Femring(R) product and Licen...
... into the healthcare IT and government services ma...Y., Jan. 12 Oleen Pinnacle Healthcare Consulting ...n Health Systems (PHS), a Central New York-based I...nt sectors. , , "We,re very excited about the pos...
...Jan. 12 /PRNewswire-FirstCall/ - DiagnoCure Inc. (... high-value cancer diagnostic tests and delivering...agnoCure Oncology Laboratories based in West Chest...y 15th in San Francisco, California. The Company i...
..., , MOUNT OLIVE, N.J., Jan 12 InSet Technologies...mable implantable pumps for targeted delivery of m...inancing totaling $25 million. , , Clarus Venture...ncing, Kurt C. Wheeler of Clarus Ventures will joi...
...ause you are traveling or,on holiday doesn,t mean ...ts.,In fact, it is an easier time to be healthy. ,...20071212/NYWFNS2 ) , Many Americans take to th...and prepackaged snacks, or extravagant and excessi...
...lthcare Technology will be holding a developers su...eTesting 2.0 with their software platform. , ...nalysts and industry-watchers believe that cloud c...e companies. , , ,Amistaff Healthcare Technology, ...
Other Medicine News:Health News:Warner Chilcott and Watson Pharmaceuticals Announce Agreements on Loestrin(R) 24 and Femcon(R) Fe Patent Litigation 2Health News:Warner Chilcott and Watson Pharmaceuticals Announce Agreements on Loestrin(R) 24 and Femcon(R) Fe Patent Litigation 3Health News:Warner Chilcott and Watson Pharmaceuticals Announce Agreements on Loestrin(R) 24 and Femcon(R) Fe Patent Litigation 4Health News:Warner Chilcott and Watson Pharmaceuticals Announce Agreements on Loestrin(R) 24 and Femcon(R) Fe Patent Litigation 5Health News:Oleen Pinnacle Announces Acquisition of Partners in Health Systems 2Health News:Previstage(TM) GCC to be presented at ASCO GI 2Health News:Previstage(TM) GCC to be presented at ASCO GI 3Health News:Previstage(TM) GCC to be presented at ASCO GI 4Health News:InSet Technologies Completes $25 Million Financing 2Health News:Actress, Author Mariel Hemingway & Travelers Advantage Say: Traveling is a Time to be Even Healthier 2Health News:Actress, Author Mariel Hemingway & Travelers Advantage Say: Traveling is a Time to be Even Healthier 3Health News:Actress, Author Mariel Hemingway & Travelers Advantage Say: Traveling is a Time to be Even Healthier 4Health News:NurseTesting 2.0 Goes to the Clouds and Invites Developers to Summit 2Health News:NurseTesting 2.0 Goes to the Clouds and Invites Developers to Summit 3
(Date:11/30/2009)..., Nov. 30 Reportlinker.com announc...in its catalogue: ,, Inflammatory Disorders: T...nse ,, http://www.reportlinker.com/p0165600/I...alance-the-Immune-Response.html ,, The human i...vidual body or producing an exaggerated response t...
(Date:11/30/2009)... Mass., Nov. 30 According to Mille...n medical technology market intelligence, the near...clined by almost 5% over 2008 as patients chose to...omic crisis. The market will, however, begin recov...g pre-recession growth rates of over 15%. MRG,s fa...
(Date:11/30/2009)...d CHICAGO, Nov. 30 Today at the 95... Radiological Society of North America (RSNA), Bay...nrollment of the first patient in an international... and safety of florbetaben (BAY 94-9172) PET imagi... brain, which are a pathological hallmark of Alzhe...
Breaking Medicine Technology:Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 2Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 3Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 4Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 5Facial Injectables Emerge From the Recession 2Facial Injectables Emerge From the Recession 3Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 2Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 3The right messenger for a healthy immune response 9284 1The right messenger for a healthy immune response 9284 2Chasing tiny vehicles 9282 1Chasing tiny vehicles 9282 2Chasing tiny vehicles 9282 3Our brain looks at eyes first to identify a face 9280 1Our brain looks at eyes first to identify a face 9280 2Our brain looks at eyes first to identify a face 9280 3
...ved at Two Dose Levels with No Reversal of Analges...peutics (Nasdaq: NKTR ) announced positive topli...omized, placebo-controlled study of NKTR-118 in pa...TR-118, a peripheral opioid antagonist, is an oral... most common and debilitating manifestation of opi...
...,Biosciences (Nasdaq: HNAB ) today announced tha...has completed a planned, pre-specified safety revi...clinical trial of Marqibo(R) (vincristine,sulfate ...ute lymphoblastic,leukemia (ALL) in second relapse...ort the acceptable safety profile observed with Ma...
Other Medicine Technology:Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC) 2Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC) 3Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC) 4Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC) 5Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC) 6Hana Biosciences Announces Successful Planned Independent Safety Analysis Supports Ability to Complete Pivotal rALLy Clinical Trial of Marqibo, Its Lead Novel Anti-Cancer Compound 2Hana Biosciences Announces Successful Planned Independent Safety Analysis Supports Ability to Complete Pivotal rALLy Clinical Trial of Marqibo, Its Lead Novel Anti-Cancer Compound 3Hana Biosciences Announces Successful Planned Independent Safety Analysis Supports Ability to Complete Pivotal rALLy Clinical Trial of Marqibo, Its Lead Novel Anti-Cancer Compound 4Hana Biosciences Announces Successful Planned Independent Safety Analysis Supports Ability to Complete Pivotal rALLy Clinical Trial of Marqibo, Its Lead Novel Anti-Cancer Compound 5
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
Medicine Products: